Brands :

Klonopin (Clonazepam)

Category: Anti-Anxiety ; Minimal price: 121 EUR

Available dose :

Commercial Name: Klonopin, Rivotril

Principal Ingredient: Clonazepam

Utilization: Anti-Anxiety

Available Dosage: 0,5 mg, 1 mg, 2 mg

This product is shipped from EU

Anxiety is not just an emotion. From more mild forms to social anxiety disorder and unjustified phobias, anxiety may bring a lot of problems for the person who experiences it. The person feels fear and unsafe, can't respond calmly and rationally to the situations of social interaction, changes of the environment, and even those everyday challenges which in fact are quite habitual. Understanding of the fact that all the fears and suspicions aren?��t reasonable often makes the person feel blame for incapacity to control their own condition so the anxiety increases and the person just goes around in circles. Such disorders typically affect the social and professional life, so it's no sense to ignore them!
It may be a good idea to recourse to cognitive-behavioral therapy, but nevertheless, good anti-anxiety drugs will be helpful, speeding up the process of recovery and eliminating such symptoms as fast pulse, trembling, fatigue, and weakness.

Buy online Klonopin (Clonazepam) prescriptions free

Also available for sale the next products Anti-Anxiety:

Atarax :Buy Atarax (Hydroxyzine) Anti-Anxiety 25 mg 60 pills 56 EUR

Ativan :Buy Ativan (Lorazepam) Anti-Anxiety 1 mg 30 pills 142 EUR

Buspar :Buy Buspar (Buspirone) Anti-Anxiety 5 mg 90 pills 58 EUR

Klonopin :Buy Klonopin (Clonazepam) Anti-Anxiety 2 mg (EU2EU) 30 pills 121 EUR

Lexotanil :Buy Lexotanil (Bromazepam) Anti-Anxiety 6 mg 30 pills 196 EUR

Rivotril Brand :Buy Rivotril Brand Anti-Anxiety 2 mg 30 pills 203 EUR

Valium :Buy Valium (Diazepam) Anti-Anxiety 10 mg (EU2EU) 30 pills 169 EUR

Valium Brand :Buy Valium Brand Anti-Anxiety 10 mg 30 pills 199 EUR

Xanax :Buy Xanax (Alprazolam) Anti-Anxiety 1 mg (EU2EU) 30 pills 189 EUR

Xanax Brand :Buy Xanax Brand Anti-Anxiety 0,5 mg 30 pills 199 EUR

Full index products:

Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. In patients with absence seizures (petit mal) who have failed to respond to succinimides, Klonopin may be useful.

SIDE EFFECTS

The adverse experiences for Klonopin are provided separately for patients with seizure disorders and with panic disorder.

Seizure Disorders

The most frequently occurring side effects of Klonopin are referable to CNS depression. Experience in treatment of seizures has shown that drowsiness has occurred in approximately 50% of patients and ataxia in approximately 30%. In some cases, these may diminish with time; behavior problems have been noted in approximately 25% of patients. Others, listed by system, including those identified during postapproval use of Klonopin are:

Cardiovascular: Palpitations

Dermatologic: Hair loss, hirsutism, skin rash, ankle and facial edema

Gastrointestinal: Anorexia, coated tongue, constipation, diarrhea, dry mouth, encopresis, gastritis, increased appetite, nausea, sore gums

Genitourinary: Dysuria, enuresis, nocturia, urinary retention

Hematopoietic: Anemia, leukopenia, thrombocytopenia, eosinophilia

Hepatic: Hepatomegaly, transient elevations of serum transaminases and alkaline phosphatase

Musculoskeletal: Muscle weakness, pains

Miscellaneous: Dehydration, general deterioration, fever, lymphadenopathy, weight loss or gain

Neurologic: Abnormal eye movements, aphonia, choreiform movements, coma, diplopia dysarthria, dysdiadochokinesis, ?�??�?glassy-eyed?��?�� appearance, headache, hemiparesis, hypotonia, nystagmus, respiratory depression, slurred speech, tremor, vertigo

Psychiatric: Confusion, depression, amnesia, hysteria, increased libido, insomnia, psychosis (the behavior effects are more likely to occur in patients with a history of psychiatric disturbances).

The following paradoxical reactions have been observed: irritability, aggression, agitation, nervousness, hostility, anxiety, sleep disturbances, nightmares, abnormal dreams, hallucinations.

Respiratory: Chest congestion, rhinorrhea, shortness of breath, hypersecretion in upper respiratory passages

Panic Disorder

Adverse events during exposure to Klonopin were obtained by spontaneous report and recorded by clinical investigators using terminology of their own choosing. Consequently, it is not possible to provide a meaningful estimate of the proportion of individuals experiencing adverse events without first grouping similar types of events into a smaller number of standardized event categories. In the tables and tabulations that follow, CIGY dictionary terminology has been used to classify reported adverse events, except in certain cases in which redundant terms were collapsed into more meaningful terms, as noted below.

The stated frequencies of adverse events represent the proportion of individuals who experienced, at least once, a treatment-emergent adverse event of the type listed. An event was considered treatment-emergent if it occurred for the first time or worsened while receiving therapy following baseline evaluation.

Adverse Findings Observed In Short-Term, Placebo-Controlled Trials

Adverse Events Associated With Discontinuation Of Treatment

Overall, the incidence of discontinuation due to adverse events was 17% in Klonopin compared to 9% for placebo in the combined data of two 6- to 9-week trials.